{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:22:28Z","timestamp":1745760148730},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.leukres.2011.07.026","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T22:32:35Z","timestamp":1313533955000},"page":"e215-e216","source":"Crossref","is-referenced-by-count":5,"title":["Nilotinib therapy does not induce consistent modifications of cholesterol metabolism resulting in clinical consequences"],"prefix":"10.1016","volume":"35","author":[{"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Loglisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioia","family":"Colafigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Salaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.07.026_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2009.08.031","article-title":"Nilotinib: a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia","volume":"34","author":"Breccia","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.07.026_bib0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2010-03-277152","article-title":"Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase following imatinib resistance or intolerance: 24-month follow-up results","volume":"117","author":"Kantarjian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.026_bib0015","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.359.359","article-title":"Excellent outcomes at 3 years with nilotinib 800mg daily in early chronic phase Ph+ chronic myeloid leukemia (CML): results of a phase 2 GIMEMA CML WP Clinical Trial","volume":"116","author":"Rosti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.026_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2009.25.4896","article-title":"Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase","volume":"28","author":"Cortes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.07.026_bib0025","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2011.07.026_bib0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.leukres.2007.01.024","article-title":"Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib","volume":"31","author":"Breccia","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.07.026_bib0035","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood.V110.11.4588.4588","article-title":"Analysis of glucose profiles in imatinib-resistant or intolerant chronic myelogenous leukemia (CML) patients treated with nilotinib: lack of correlation between glucose levels and nilotinib efficacy","volume":"110","author":"le Coutre","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.026_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.22037","article-title":"Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML","author":"Aichberger","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2011.07.026_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.leukres.2011.07.026_bib0050","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.2353\/ajpath.2009.080734","article-title":"Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization","volume":"175","author":"Ahmad","year":"2009","journal-title":"Am J Pathol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T09:49:29Z","timestamp":1592819369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0145212611003730"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.07.026","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}